从压力定量吸入器换用干粉吸入器对气候排放与哮喘控制的影响:事后分析
本事后分析基于Salford哮喘真实世界研究中的2236例(53%)基线使用pMDI控制药物的患者,随机分为换用FF/VI干粉吸入器组(n=1081)与继续常规治疗组(n=1155)。结果显示换用DPI组年人均CO2e显著低于常规治疗组,且12个月内哮喘控制持续更优。
要点
- 换用FF/VI干粉吸入器后年人均CO2e由240 kg降至108 kg
- 换用DPI未损失哮喘控制,ACT应答者比例持续更优
- 残余碳足迹可通过换用DPI或低碳酸的缓解药物进一步降低
核心结论
- 从pMDI换用DPI维持治疗使吸入器碳足迹减少一半以上,且不损失哮喘控制。
- 两组哮喘控制均改善,FF/VI DPI组控制更优。
研究设计与样本
- 基于Salford哮喘真实世界研究的事后分析,纳入基线使用pMDI控制治疗的2236例(53%)患者。
- 随机分为FF/VI经ELLIPTA DPI治疗组(n=1081)与继续常规治疗组(n=1155),管理条件接近日常临床实践。
主要发现
- 年人均CO2e(维持加缓解治疗)FF/VI DPI组最小二乘几何均值108 kg(95%CI 102至114),常规治疗组240 kg(95%CI 229至252),p<0.001。
- 12个月内FF/VI DPI组哮喘控制持续优于常规治疗组。
- 两组人口学特征与基线ACT总分匹配良好(平均年龄49岁;平均ACT评分常规治疗16.6,FF/VI 16.5)。
关键数值与推荐
- 哮喘控制以ACT应答者比例评估,即ACT总分≥20和/或较基线增加≥3的复合指标。
- 年CO2e按维持与缓解吸入器总处方量计算,单位为kg。
临床怎么用
- 对使用pMDI维持治疗的哮喘患者,可考虑换用DPI以降低吸入器碳足迹而不影响控制。
- 残余碳足迹可进一步通过换用DPI或低碳酸缓解吸入器降低。
局限性
- 为事后分析,仅纳入基线使用pMDI控制治疗的患者亚组。
- 碳足迹基于处方吸入器数量估算,未涵盖原文之外的其他排放来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the effects of switching from a pressurised metered dose inhaler (pMDI)-based to a dry powder inhaler (DPI)-based maintenance therapy versus continued usual care on greenhouse gas emissions (carbon dioxide equivalents, CO2e) and asthma control. METHODS: This post-hoc analysis was based on a subset of 2236 (53%) patients from the Salford Lung Study in Asthma who at baseline were using a pMDI-based controller therapy. During the study patients were randomised to fluticasone furoate/vilanterol (FF/VI) via the ELLIPTA DPI (switched from pMDI to DPI) (n=1081) or continued their usual care treatment (n=1155), and were managed in conditions close to everyday clinical practice. Annual CO2e (kg) was calculated for the total number of maintenance and rescue inhalers prescribed. Asthma control was assessed by the proportion of ACT responders (composite of ACT total score ≥20 and/or increase from baseline ≥3). RESULTS: The groups were well matched for demographic characteristics and baseline Asthma Control Test (ACT) total score (mean age: 49 years; mean ACT score: usual care, 16.6; FF/VI, 16.5). Annual CO2e kg per patient (maintenance plus rescue therapy) was significantly lower with FF/VI DPI treatment ('switch' group) than usual care (least squares geometric mean 108 kg (95% CI 102 to 114) vs 240 kg (95% CI 229 to 252), p<0.001). Asthma control was consistently superior over the 12 months in the FF/VI DPI group compared with usual care. CONCLUSIONS: Patients switching from a pMDI-based to a DPI-based maintenance therapy more than halved their inhaler carbon footprint without loss of asthma control. The remaining inhaler carbon footprint could be reduced through switches from pMDI to DPI rescue medications or alternative lower-carbon footprint rescue inhalers if available. Asthma control improved in both groups, with greater control demonstrated in those initiated on FF/VI DPI. TRIAL REGISTRATION NUMBER: NCT01706198.
引用
- Woodcock A, Janson C, Rees J, et al. Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis. Thorax. 2022. PMID: 35131893. doi:10.1136/thoraxjnl-2021-218088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。